1.84 USD
▼-0.07-3.42%
盘后 2.10 0.00%
2026-11-20
市值
$373.62M
市盈率
—
EPS
-0.04
股息率
—
52 周区间
1.47 – 3.47
成交量
2.07M
Beta
1.85
目标价
5.13
52W 低 1.4752W 高 3.47
价格走势
公司简介
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company also offers INTERCEPT Blood Systems for platelets plasma, and cryoprecipitation, which is designed to inactivate blood-borne pathogens in platelets and plasma do...
关联新闻
- Cerus' blood-safety system meets main goal in late-stage trial
Cerus' blood-safety system meets main goal in late-stage trial